Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-07 1:45 pm Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | Saba Capital Management L.P. | 0 0% | -1,258,277 (Position Closed) | View |
| 2023-09-11 4:36 pm Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | First Trust Capital Management L.P. | 0 0% | -2,355,502 (Position Closed) | View |
| 2023-08-08 10:29 am Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | BlackRock Inc. BLK | 0 0% | -1,500,000 (Position Closed) | View |
| 2023-08-04 2:08 pm Sale | 13D | DA32 Life Science Tech Acquisition Corp. DALS | ARCH Venture Fund XI L.P. | 5,145,000 90.5% | -1,600,000 (-23.72%) | View |
| 2023-08-02 4:10 pm Sale | 13D | DA32 Life Science Tech Acquisition Corp. DALS | Section 32 Fund 3 LP | 5,315,000 94.1% | -800,000 (-13.08%) | View |
| 2023-08-01 5:22 pm Sale | 13D | DA32 Life Science Tech Acquisition Corp. DALS | DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) | 5,145,000 91.06% | -1,600,000 (-23.72%) | View |
| 2023-08-01 4:15 pm Unchanged | 13D | DA32 Life Science Tech Acquisition Corp. DALS | DA32 Sponsor LLC | 5,115,000 90.5% | 0 (Unchanged) | View |
| 2023-05-15 5:01 pm Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | RA CAPITAL MANAGEMENT L.P. | 0 0% | -1,500,000 (Position Closed) | View |
| 2023-04-10 4:16 pm Purchase | 13G | DA32 Life Science Tech Acquisition Corp. DALS | First Trust Capital Management L.P. | 2,355,502 11.41% | 2,355,502 (New Position) | View |
| 2023-02-14 06:49 am Purchase | 13G | DA32 Life Science Tech Acquisition Corp. DALS | Saba Capital Management L.P. | 1,258,277 6.1% | 138,000 (+12.32%) | View |
| 2023-02-06 2:33 pm Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | Wellington Management Portfolios (Dublin) Public Ltd Co | 0 0% | -1,479,148 (Position Closed) | View |
| 2023-02-06 10:22 am Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | VICTORY CAPITAL MANAGEMENT INC | 0 0% | -1,126,959 (Position Closed) | View |
| 2023-01-31 1:58 pm Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | BlackRock Inc. BLK | 1,500,000 7.3% | -1,060 (-0.07%) | View |
| 2022-02-10 07:48 am Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -2,865,991 (Position Closed) | View |
| 2022-02-07 3:34 pm Purchase | 13G | DA32 Life Science Tech Acquisition Corp. DALS | Saba Capital Management L.P. | 1,120,277 5.4% | 1,120,277 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | DA32 Life Science Tech Acquisition Corp. DALS | BlackRock Inc. BLK | 1,501,060 7.3% | 1,501,060 (New Position) | View |
| 2022-02-04 09:15 am Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | WELLINGTON MANAGEMENT GROUP LLP | 2,865,991 11.17% | -242,546 (-7.80%) | View |
| 2022-02-04 07:59 am Sale | 13G | DA32 Life Science Tech Acquisition Corp. DALS | Wellington Management Portfolios (Dublin) Public Ltd Co | 1,479,148 5.77% | -105,016 (-6.63%) | View |
| 2022-02-02 2:47 pm Purchase | 13G | DA32 Life Science Tech Acquisition Corp. DALS | VICTORY CAPITAL MANAGEMENT INC | 1,126,959 5.46% | 1,126,959 (New Position) | View |
| 2021-08-10 07:57 am Purchase | 13G | DA32 Life Science Tech Acquisition Corp. DALS | WELLINGTON MANAGEMENT GROUP LLP | 3,108,537 12.12% | 3,108,537 (New Position) | View |